RIBC2 and malignant colon neoplasm: This broader expression pattern is consistent with previous studies reporting that RIBC2 and MCM3AP-AS1 are differentially expressed and clinically relevant in various human cancers beyond colon cancer, likely through mechanisms independent of m6A regulation50–52.